7
Views
9
CrossRef citations to date
0
Altmetric
Original Articles

The prevalence and clinical features of multi-drug resistant Salmonella typhi infections in Baluchistan, Pakistan

, &
Pages 515-519 | Received 25 Jan 1995, Accepted 14 Jun 1995, Published online: 15 Nov 2016

REFERENCES

  • Adam, D. (1989). Use of quinolones in pediatric patients. Reviews of Infectious Disease, 11 (Suppl. 5), 113–116.
  • Akhtar, M. A., Karamat, K. A., Malik, A. Z., Hashmi, A., Khan, Q. M. & Rashee, D. P. (1989). Efficacy of ofloxacin in typhoid fever, particularly in drug resistant cases. Reviews of Infectious Disease, 11 (Suppl. 5), 119.
  • Anand, A., Kataria, V. K., Singh, W. & Chatterjee, S. K. (1990). Epidemic multi-resistant enteric fever in Eastern India. Lancet, ii, 352.
  • Arshad, A., Naseem, S. & Tasnim, A. (1992). Enoxacin in the treatment of typhoid fever. Clinical Therapeutics, 14, 825–828.
  • Bhutta, Z. A., Naqvi, S. H., Razzaq, R. A. & Farooqui, B. J. (1991). Multi-drug resistant typhoid in children: presentation and clinical features. Reviews of Infectious Diseases, 13, 832–836.
  • Chandra, R., Sirinivasan, S., Nalini, P. & Rao, R. S. (1992). Multi-drug resistant enteric fever. Journal of Tropical Medicine and Hygiene, 95, 284–287.
  • Cuevas, L. E., Kazembe, P., Mughogho, G. K., Tillotson, G. S. & Hart, C. A. (1995). Eradication of nasopharyngeal carriage of Neisseria meningitidis in children in rural Africa: a comparison of ciprofloxacin and rifampicin. Journal of Infectious Diseases, 171, 728–731.
  • Datta, N., Richards, H. & Dalta, C. (1981). Salmonella typhi in vivo acquires resistance to both chloramphenicol and cotrimoxazole. Lancet, i, 1181–1183.
  • Edelman, R. & Levine, M. M. (1986). Summary of an international workshop on typhoid fever. Reviews of Infectious Diseases, 8, 329–349.
  • Geddes, A. M., Pugh, R. N. H. & Nye, F. J. (1975). Treatment and follow-up studies with cotrimoxazole in enteric fever and in typhoid carriers. Journal of Antimicrobial Chemotherapy, 1, 51–54.
  • Gupta, A. (1994). Multidrug-resistant typhoid fever in children: epidemiology and therapeutic approach. Pediatric Infectious Diseases, 13, 134–140.
  • Hien, T. T., Bethell, D. B., Hoa, N. T. T., Wain, J., Diep, T. S., Phi, L. T., Cuong, B. M., Duong, N. M., Tranh, P. T., Walsh, A. L., Day, N. P. J. & White, N. J. (1995). Short course of ofloxacin for treatment of multi-drug resistant typhoid. Clinical Infectious Diseases, 20, 917–923.
  • Karamat, K. A., Akhtar, M. A., Malik, I. A., Hayat, R., Ud Din, Z., Akhtar, J., Qamar, R. H. & Qureshi, A. H. (1991). Multi-drug resistant Salmonella typhi in northern Pakistan. Pakistan Journal of Pathology, 2, 37–40.
  • Karmaker, S., Biswas, D., Shaikh, N. M., Chatterjee, S. K., Kataria, V. K. & Kumar, R. (1991). Role of a large plasmid of Salmonella typhi encoding multiple drug resistance. Journal of Medical Microbiology, 34, 149–151.
  • Kubin, R. (1993). Safety and efficacy of ciprofloxacin in paediatric patients—a review. Infection, 21, 413–421.
  • Ling, J. & Chang, P. Y. (1984). Plasmid mediating resistance to chloramphenicol, trimethoprim and ampicillin in Salmonella typhi in the South East region. Journal of Infectious Diseases, 149, 652.
  • Mirza, S. H. & Hart, C. A. (1993). Plasmid-encoded multi-drug resistance in Salmonella typhi from Pakistan. Annals of Tropical Medicine and Parasitology, 87, 373–377.
  • Mourad, A. S., Metwally, M., Nour, E., Deen, A., Threlfall, E. J., Rowe, B., Mapes, T., Hedstrom, R., Bourgeois, A. L. & Murphy, J. R. (1993). Multiple-drug resistant Salmonella typhi. Clinical Infectious Diseases, 17, 135–136.
  • Olarte, J. & Galindo, E. (1973). Salmonella typhi resistant to chloramphenicol, ampicillin and other antimicrobial agents: strains isolated during an extensive typhoid fever epidemic in Mexico. Antimicrobial Agents and Chemotherapy, 4, 597–601.
  • Paniker, C. K. & Vimala, K. N. (1972). Transferable chloramphenicol resistance in Salmonella typhi. Nature, 239, 109–110.
  • Phipps, M., Pang, T., Lek Koh, C. & Puthucheary, S. (1991). Plasmid incidence rate and conjugative chloramphenicol and tetracycline resistance plasmids in Malaysian isolates of Salmonella typhi. Microbiology and Immunology, 35, 157–161.
  • Rowe, B., Ward, R. L. & Threlfall, E. J. (1992). Ciprofloxacin and typhoid fever. Lancet, i, 740.
  • Smego, R. A., Zaidi, A. K., Mohammed, Z., Butta, Z. A. & Hafeez, S. (1988). Multiply-resistant Salmonella and Shigella isolates. Acta Pathologica, Microbiologica et Immunologica Scandinavica, 96 (Suppl. 3), 65–67.
  • Stokes, E. J. & Waterworth, P. M. (1973). Antibiotic sensitivity tests by diffusion methods. Association of Clinical Pathologists Broadsheet, 55, 1–12.
  • Umasankar, S., Wall, R. A. & Berker, J. (1992). A case of ciprofloxacin resistant typhoid fever. Communicable Disease Report, 2, R138–R140.
  • Wallace, M. & Yousif, A. A. (1990). Spread of multi-resistant Salmonella typhi. Lancet, ii, 1065–1066.
  • Wallace, M. R., Yousif, A. A., Mahroos, G. A., Mapes, T., Threlfall, E. J., Rowe, B. & Hyams, K. C. (1993). Ciprofloxacin versus ceftriaxone in the treatment of multi-resistant typhoid fever. European Journal of Clinical Microbiology and Infectious Diseases, 12, 907–910.
  • Xiao, Q. L. (1987). A comparison study on the application of plasmid profile analysis, phage typing and antimicrobial susceptibility testing to the epidemiological investigation of typhoid. Chung Hua Liu Hsing Ping Hsuch Tas Chih, 8, 272–275.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.